Evidence map›Paper›PMID 30082850›Full record

ArticleBone marrow transplantation2019

Predictors of short-term and long-term mortality in critically ill patients admitted to the intensive care unit following allogeneic stem cell transplantation.

P L J van der Heiden, M S Arbous, E J van Beers, W M van den Bergh, S le Cessie, A M P Demandt, M Eefting, C Hess, N Kusadasi, W A F Marijt and 7 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Prognostic Factors and Intensive Care Outcome in Post-Transplant Phase of Hematopoietic Stem Cell Transplantation: Intensive Care Outcome in Hematopoietic Stem Cell Transplantation.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2023
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

P L J van der HeidenDepartment of Intensive Care Medicine, Leiden University Medical Center, Leiden, The Netherlands. P.L.J.van_der_Heiden@lumc.nl.
M S ArbousDepartment of Intensive Care Medicine, Leiden University Medical Center, Leiden, The Netherlands.
E J van BeersVan Creveldkliniek, University Medical Center Utrecht, Utrecht, The Netherlands.
W M van den BerghDepartment of Critical Care, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
S le CessieDepartment of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
A M P DemandtDepartment of Hematology, Maastricht University Medical Center+, Maastricht, The Netherlands.
M EeftingDepartment of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
C HessDepartment of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
N KusadasiDepartement of Intensive Care Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
W A F MarijtDepartment of Hematology, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0001-7683-4560
W N K A van MookDepartment of Intensive Care Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands.
M C A MüllerDepartment of Intensive Care Medicine, Academic Medical Center, Amsterdam, The Netherlands.
P R TuinmanDepartment of Intensive Care Medicine, VU university Medical Center, Amsterdam, The Netherlands.
M van VlietDepartment of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
D J van WesterlooDepartment of Intensive Care Medicine, Leiden University Medical Center, Leiden, The Netherlands.
N M A BlijlevensDepartment of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
HEMA-ICU Study Group
Leiden University Medical Center · NLRadboud University Nijmegen · NLAmsterdam UMC Location University of Amsterdam · NLUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Historically, the mortality of patients admitted to the ICU after allogeneic stem cell transplantation (alloSCT) is high. Advancements in transplantation procedures, infectious monitoring and supportive care may have improved the outcome. This study aimed to determine short-term and long-term mortality after ICU admission of patients after alloSCT and to identify prognostic clinical and transplantation-related determinants present at ICU admission for long-term outcome. A multicenter cohort study was performed to determine 30-day and 1-year mortality within 2 years following alloSCT. A total of 251 patients were included. The 30-day and 1-year mortality was 55% and 80%, respectively. Platelet count <25 × 10

Indexed as

AdultCritical IllnessHematopoietic Stem Cell TransplantationHumansIntensive Care UnitsMiddle AgedTransplantation ConditioningTransplantation, Homologous

Identifiers

PMID30082850
OpenAlexW2887461754

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.